がん領域の栄養市場：がん、投与経路、エンドユーザー別-2025～2030年の世界予測

がん領域の栄養市場は、2023年に30億6,000万米ドルと評価され、2024年には33億2,000万米ドルに達すると予測され、CAGR 8.61％で成長し、2030年には54億6,000万米ドルに達すると予測されています。

がん領域の栄養の対象範囲には、治療と回復を通してがん患者をサポートするために調整された食事戦略が含まれ、栄養状態の改善、副作用の管理、生活の質の向上に重点が置かれています。このような栄養の必要性は、がんによって誘発される代謝の変化と治療に関連した副作用から生じており、体重、筋肉量、免疫機能を維持するためにオーダーメイドの栄養介入が不可欠です。個別の食事計画や補給から栄養不良や悪液質への対応まで、その応用範囲は多岐にわたります。最終用途の範囲には、患者に包括的な栄養サポートを提供する病院、専門クリニック、在宅ケアの現場などが含まれます。この市場の主要成長要因としては、世界のがん罹患率の増加、がん治療における栄養の重要性に対する意識の高まり、栄養診断の技術的進歩などが挙げられます。新たなビジネス機会は、遺伝子やマイクロバイオームのデータ別の個別化栄養療法にあり、これにより治療成績を大幅に改善できる個別化計画が可能になります。このような機会を生かすための研究開発には、腫瘍医や栄養士との研究協力に投資して正確な食事ガイドラインを開発することや、栄養ゲノミクスソリューションのためのバイオテクノロジー企業との提携を促進することなどが含まれます。成長の可能性があるにもかかわらず、高額な治療費、償還の問題、がん種による食事要件のばらつきなどの課題が市場拡大の妨げになる可能性があります。植物由来の栄養補助食品、非侵襲的栄養評価ツール、治療計画を最適化するための遠隔患者モニタリング用デジタルプラットフォームのセグメントでイノベーションを追求することができます。がん特有のニーズに合わせて調整された機能性食品を掘り下げることも、有望な研究手段となります。がん領域の栄養市場の性質はダイナミックであり、統合ケアを重視する進化する医療パラダイムがその原動力となっています。この市場で成功するには、臨床研究、規制開発、消費者の嗜好に遅れをとらず、競合を維持し、急成長するセグメントで有意義な患者の転帰を促進することが必要です。

市場力学：急速に進化するがん領域の栄養市場の主要市場洞察を公開

がん領域の栄養市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がん患者の増加
  • がん患者の栄養補給に対する需要の高まり
  • 高度医療施設に対する認識とアクセシビリティの向上
• 市場抑制要因
  • がん患者向け高級栄養製品の高コスト
• 市場機会
  • がん患者用栄養補給製剤の進歩
  • 食道切除術を受けるがん患者向けの免疫強化栄養剤
• 市場課題
  • 製造に伴う複雑さ

ポーターのファイブフォース：がん領域の栄養市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：がん領域の栄養市場における外部からの影響の把握

外部マクロ環境要因は、がん領域の栄養市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：がん領域の栄養市場における競合情勢の把握

がん領域の栄養市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：がん領域の栄養市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、がん領域の栄養市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：がん領域の栄養市場における成功への道筋を描く

がん領域の栄養市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がん罹患率の上昇
    • 腫瘍学患者に対する栄養補給の需要増加
    • 先進的医療施設に対する認知度とアクセスの向上
  • 抑制要因
    • 腫瘍学向けの高級栄養製品の高コスト
  • 機会
    • 腫瘍栄養補給配合の進歩
    • 食道切除術を受けるがん患者のための免疫増強配合
  • 課題
    • 生産に伴う複雑さ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 がん領域の栄養市場：がん別

• イントロダクション
• 胸
• 頭頸部
• 肝臓
• 肺
• 膵臓
• 胃と消化器

第7章 がん領域の栄養市場：投与経路別

• イントロダクション
• 経口
• 非経口

第8章 がん領域の栄養市場：エンドユーザー別

• イントロダクション
• 在宅医療
• 病院
• 専門クリニック

第9章 南北アメリカのがん領域の栄養市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のがん領域の栄養市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのがん領域の栄養市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• B. Braun SE
• Baxter International, Inc.
• BioSig Technologies, Inc.
• Danone S.A.
• FMC Corporation
• Fresenius Kabi AG
• Global Health Products, Inc.
• Healios Oncology Nutrition, LLC
• Hormel Foods Corporation
• Meiji Holdings Co., Ltd.
• Nestle S.A.
• Nutra Healthcare Private Limited
• OnCore Nutrition

LIST OF FIGURES

• FIGURE 1. ONCOLOGY NUTRITION MARKET RESEARCH PROCESS
• FIGURE 2. ONCOLOGY NUTRITION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ONCOLOGY NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ONCOLOGY NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ONCOLOGY NUTRITION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ONCOLOGY NUTRITION MARKET DYNAMICS
• TABLE 7. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY BREAST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HEAD & NECK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PANCREATIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY STOMACH & GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 32. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 49. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 52. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 104. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 116. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 119. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. ONCOLOGY NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. ONCOLOGY NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

The Oncology Nutrition Market was valued at USD 3.06 billion in 2023, expected to reach USD 3.32 billion in 2024, and is projected to grow at a CAGR of 8.61%, to USD 5.46 billion by 2030.

The scope of oncology nutrition encompasses dietary strategies tailored to support cancer patients throughout their treatment and recovery, focusing on improving nutritional status, managing side effects, and enhancing quality of life. The necessity of such nutrition arises from cancer-induced metabolic changes and treatment-related side effects, making tailored nutritional interventions essential for maintaining body weight, muscle mass, and immune function. Applications range from individualized meal planning and supplementation to addressing malnutrition and cachexia. End-use scope includes hospitals, specialty clinics, and home care settings providing comprehensive nutritional support to patients. Key growth factors in this market include increasing global cancer prevalence, heightened awareness of the importance of nutrition in cancer care, and technological advancements in nutritional diagnostics. Emerging opportunities lie in personalized nutrition based on genetic and microbiome data, which enables individualized plans that can significantly improve therapeutic outcomes. Recommendations for capitalizing on these opportunities include investing in research collaborations with oncologists and dietitians to develop precise dietary guidelines and fostering partnerships with biotechnology firms for nutritional genomics solutions. Despite the growth potential, challenges such as high treatment costs, reimbursement issues, and variability in dietary requirements across different cancer types may hinder market expansion. Innovations can be pursued in the areas of plant-based nutritional supplements, non-invasive nutritional assessment tools, and digital platforms for remote patient monitoring to optimize treatment plans. Delving into functional foods tailored for cancer-specific needs also presents a promising research avenue. The nature of the oncology nutrition market is dynamic, driven by evolving healthcare paradigms that emphasize integrative care. Success in this market necessitates staying abreast of clinical research, regulatory developments, and consumer preferences to remain competitive and drive meaningful patient outcomes in a burgeoning field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oncology Nutrition Market

The Oncology Nutrition Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cancer cases
  • Growing demand for nutritional feeding for oncology patients
  • Increased awareness and accessibility to advanced healthcare facilities
• Market Restraints
  • High cost of premium nutrition products for oncology
• Market Opportunities
  • Advancement of oncology nutritional feeding formulas
  • Immune-enhancing formulas for patients with cancer undergoing esophagectomy
• Market Challenges
  • Complexities associated with the production

Porter's Five Forces: A Strategic Tool for Navigating the Oncology Nutrition Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oncology Nutrition Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oncology Nutrition Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oncology Nutrition Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oncology Nutrition Market

A detailed market share analysis in the Oncology Nutrition Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oncology Nutrition Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oncology Nutrition Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oncology Nutrition Market

A strategic analysis of the Oncology Nutrition Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oncology Nutrition Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Baxter International, Inc., BioSig Technologies, Inc., Danone S.A., FMC Corporation, Fresenius Kabi AG, Global Health Products, Inc., Healios Oncology Nutrition, LLC, Hormel Foods Corporation, Meiji Holdings Co., Ltd., Nestle S.A., Nutra Healthcare Private Limited, and OnCore Nutrition.

Market Segmentation & Coverage

This research report categorizes the Oncology Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Cancer, market is studied across Breast, Head & Neck, Liver, Lung, Pancreatic, and Stomach & Gastrointestinal.
• Based on Route of Administration, market is studied across Oral and Parenteral.
• Based on End-user, market is studied across Home Care, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cancer cases
    • 5.1.1.2. Growing demand for nutritional feeding for oncology patients
    • 5.1.1.3. Increased awareness and accessibility to advanced healthcare facilities
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of premium nutrition products for oncology
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement of oncology nutritional feeding formulas
    • 5.1.3.2. Immune-enhancing formulas for patients with cancer undergoing esophagectomy
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities associated with the production
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Oncology Nutrition Market, by Cancer

• 6.1. Introduction
• 6.2. Breast
• 6.3. Head & Neck
• 6.4. Liver
• 6.5. Lung
• 6.6. Pancreatic
• 6.7. Stomach & Gastrointestinal

7. Oncology Nutrition Market, by Route of Administration

• 7.1. Introduction
• 7.2. Oral
• 7.3. Parenteral

8. Oncology Nutrition Market, by End-user

• 8.1. Introduction
• 8.2. Home Care
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Oncology Nutrition Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Oncology Nutrition Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Oncology Nutrition Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. B. Braun SE
• 3. Baxter International, Inc.
• 4. BioSig Technologies, Inc.
• 5. Danone S.A.
• 6. FMC Corporation
• 7. Fresenius Kabi AG
• 8. Global Health Products, Inc.
• 9. Healios Oncology Nutrition, LLC
• 10. Hormel Foods Corporation
• 11. Meiji Holdings Co., Ltd.
• 12. Nestle S.A.
• 13. Nutra Healthcare Private Limited
• 14. OnCore Nutrition